Journal of Cancer Science and Research
Open Access

Biomarker Of Cancers

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is important that they undergo rigorous evaluation, including analytical validation, clinical validation, and assessment of clinical utility, prior to incorporation into routine clinical care. In this review we address key steps in the development of biomarkers, including ways to avoid introducing bias and guidelines to follow when reporting results of biomarker studies. Highlights

â–º Cancer biomarkers must undergo rigorous analytic and clinical validation. â–º Clinical validity must be established before a biomarker is used in the clinic. â–º Guidelines have been established for reporting results of tumor marker studies.